Lower doses of recombinant porcine factor VIII maintain excellent haemostatic efficacy

K. Martin, R. Kasthuri, M. J. Mooberry, S. L. Chen, N. S. Key, A. D. Ma*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

12 Scopus citations
Original languageEnglish (US)
Pages (from-to)e549-e551
JournalHaemophilia
Volume22
Issue number6
DOIs
StatePublished - Nov 1 2016

Funding

This work was supported by the National Institutes of Health National Heart, Lung, and Blood institute T32 HL007149 (K.M.).

ASJC Scopus subject areas

  • Genetics(clinical)
  • Hematology

Cite this